HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 20 filers reported holding HEMISPHERX BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $7,000 | -61.1% | 36,000 | -55.0% | 0.00% | -66.7% |
| Q1 2015 | $18,000 | -5.3% | 80,000 | +6.7% | 0.00% | 0.0% |
| Q4 2014 | $19,000 | -26.9% | 75,000 | -8.0% | 0.00% | -25.0% |
| Q3 2014 | $26,000 | -25.7% | 81,500 | -26.9% | 0.00% | -33.3% |
| Q2 2014 | $35,000 | -40.7% | 111,500 | -23.9% | 0.01% | -40.0% |
| Q1 2014 | $59,000 | +43.9% | 146,500 | -6.4% | 0.01% | 0.0% |
| Q4 2013 | $41,000 | – | 156,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 190,000 | $521,000 | 0.65% |
| WEDBUSH SECURITIES INC | 80,000 | $18,000 | 0.00% |
| CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 290,000 | $66,120,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20,792 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 235,051 | $53,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $204,000 | 0.00% |
| STATE STREET CORP | 81,000 | $18,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 37,501 | $9,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,735 | $6,000 | 0.00% |